| This article has been cited by |
| 1 | Effects of bromocriptine mesylate on homocysteine and high-sensitivity C-reactive protein levels in patients with type-2 diabetes mellitus | |
| Mitra Niafar,Leili Pourafkari,Kavus Shahsavarinia,Nushin Milanchian,Farhad Niafar,Nader Nader |
| Journal of Cardiovascular and Thoracic Research.2016;8(1)8 |
| [DOI] |
|
| 2 | Bromocriptine Mesylate for Glycemic Management in Type 2 Diabetes Mellitus | |
| Jessica L Kerr,Erin M Timpe,Katherine A Petkewicz |
| Annals of Pharmacotherapy.2010;44(11)1777 |
| [DOI] |
|
| 3 | A Systematic Account of Pathogenesis, Diagnosis and Pharmacotherapy of Metabolic Syndrome: Things We Need to Know | |
| R. Mahajan,K. Gupta,V. Kapoor |
| International Journal of Pharmacology.2010;6(4)338 |
| [DOI] |
|
| 4 | The Effect of Long-Term Intranasal Serotonin Treatment on Metabolic Parameters and Hormonal Signaling in Rats with High-Fat Diet/Low-Dose Streptozotocin-Induced Type 2 Diabetes | |
| Kira V. Derkach,Vera M. Bondareva,Oxana V. Chistyakova,Lev M. Berstein,Alexander O. Shpakov |
| International Journal of Endocrinology.2015;2015(4)1 |
| [DOI] |
|
| 5 | The Effect of Long-Term Intranasal Serotonin Treatment on Metabolic Parameters and Hormonal Signaling in Rats with High-Fat Diet/Low-Dose Streptozotocin-Induced Type 2 Diabetes | |
| Patricio Atanes,Shanta J. Persaud |
| International Journal of Endocrinology.2020;2015(4)367 |
| [DOI] |
|
| 6 | The effect of 2-month bromocriptine treatment on the activity of the adenylyl cyclase signaling system in the myocardium and testes of rats with type 2 diabetes | |
| K. V. Derkach,V. M. Bondareva,I. V. Moiseyuk,A. O. Shpakov |
| Cell and Tissue Biology.2015;9(5)395 |
| [DOI] |
|
| 7 | Brain signaling systems in the Type 2 diabetes and metabolic syndrome: promising target to treat and prevent these diseases | |
| Alexander O Shpakov,Kira V Derkach,Lev M Berstein |
| Future Science OA.2015;1(3)395 |
| [DOI] |
|
| 8 | Sugar-Lowering Drugs for Type 2 Diabetes Mellitus and Metabolic Syndrome—Review of Classical and New Compounds: Part-I | |
| Lev M Vieira,Lev M Souto,Lev M Sánchez-López,Lev M Machado,Lev M Severino,Lev M Jose,Lev M Santini,Lev M Fortuna,Lev M García,Lev M Silva,Lev M Souto |
| Pharmaceuticals.2019;12(4)152 |
| [DOI] |
|
| 9 | Unravelling the utility of modern sulfonylureas from cardiovascular outcome trials and landmark trials: expert opinion from an international panel | |
| S. Kalra,S. Ghosh,A.K. Das,T. Nair,S. Bajaj,G. Priya,R.N. Mehrotra,S. Das,P. Shah,V. Deshmukh,M. Chawla,D. Sanyal,S. Chandrasekaran,D. Khandelwal,A. Joshi,F. Eliana,H. Permana,M.D. Fariduddin,P.K. Shrestha,D. Shrestha,S. Kahandawa,M. Sumanathilaka,A. Shaheed,A.A. Rahim,A. Orabi,A. Al-ani,W. Hussein,D. Kumar,K. Shaikh |
| Indian Heart Journal.2020;72(1)7 |
| [DOI] |
|
| 10 | Therapeutic Approaches for Zika Virus Infection of the Nervous System | |
| Rachel P. M. Abrams,Jamie Solis,Avindra Nath |
| Neurotherapeutics.2017;14(4)1027 |
| [DOI] |
|
| 11 | Influence of Bromocriptine Plus Metformin Treatment on Glycaemia and Blood Pressure in Patients with Type 2 Diabetes Mellitus | |
| Alfredo Briones-Aranda,Javier Ramírez-Carballo,Bernardo Alfredo Romero Gómez,Victor Manuel Vega Villa,Manuela Castellanos Pérez,Esmeralda Garcia Parra,Hugo Roberto Santeliz-Montero |
| Romanian Journal of Diabetes Nutrition and Metabolic Diseases.2018;25(1)59 |
| [DOI] |
|
| 12 | Protective Role of Sarpogrelate in Combination with Bromocriptine and Cabergoline for Treatment of Diabetes in Alloxan-induced Diabetic Rats | |
| Mohammed Fouad Shalaby,Hekma A. Abd El Latif,Mohamed El Yamani,May Ahmed Galal,Sherifa Kamal,Ikhlas Sindi |
| Current Therapeutic Research.2021;95(1)100647 |
| [DOI] |
|
| 13 | Perioperative management of diabetes in patients undergoing bariatric and metabolic surgery: a narrative review and the Cleveland Clinic practical recommendations | |
| Oscar L. Morey-Vargas,Ali Aminian,Karen Steckner,Keren Zhou,Sangeeta R. Kashyap,Derrick Cetin,Kevin M. Pantalone,Christopher Daigle,Marcio L. Griebeler,W. Scott Butsch,Robert Zimmerman,Matthew Kroh,Hussein F. Saadi,Danielle Diemer,Bartolome Burguera,Raul J. Rosenthal,M. Cecilia Lansang |
| Surgery for Obesity and Related Diseases.2022;18(8)1087 |
| [DOI] |
|
| 14 | Dopamine 2 agonists for the management of type 2 diabetes: a systematic review and meta-analysis | |
| Beyene Dereje,Aschalew Nardos |
| Journal of Diabetes & Metabolic Disorders.2023;18(8)1087 |
| [DOI] |
|
| 15 | Inhibition of NLRP3 and Golph3 ameliorates diabetes-induced neuroinflammation in vitro and in vivo | |
| Yuan Li,Haifeng Zhang,Weihong Long,Menghan Gao,Weiying Guo,Lu Yu |
| Aging.2022;14(21)8745 |
| [DOI] |
|
| 16 | Circadian rhythms and pancreas physiology: A review | |
| Karl Chan,F. Susan Wong,James Alexander Pearson |
| Frontiers in Endocrinology.2022;13(21)8745 |
| [DOI] |
|
| 17 | Antihyperglycemic, Antihyperlipidemic and Cardioprotective Profile of Bromocriptine, Glibenclamide and Metformin Combination in Dexamethasone-induced Hyperglycemic Rats | |
| Adejuwon Adewale Adeneye,Joseph Abayomi Olagunju |
| Pharmacologia.2012;3(12)665 |
| [DOI] |
|
| 18 | Development of a Rapid Insulin Assay by Homogenous Time-Resolved Fluorescence | |
| Zachary J. Farino,Travis J. Morgenstern,Julie Vallaghe,Nathalie Gregor,Prashant Donthamsetti,Paul E. Harris,Nicolas Pierre,Robin Freyberg,Fabienne Charrier-Savournin,Jonathan A. Javitch,Zachary Freyberg,Faramarz Dehghani |
| PLOS ONE.2016;11(2)e0148684 |
| [DOI] |
|
| 19 | Development of a Rapid Insulin Assay by Homogenous Time-Resolved Fluorescence | |
| Kyriaki Savva,Margarita Zachariou,Anastasis Oulas,George Minadakis,Kleitos Sokratous,Nikolas Dietis,George M. Spyrou |
| PLOS ONE.2019;11(2)85 |
| [DOI] |
|
| 20 | Therapeutic potential of dopamine agonists in the treatment of type 2 diabetes mellitus | |
| Md. Tanvir Kabir,Jannatul Ferdous Mitu,Raushanara Akter,Muhammad Furqan Akhtar,Ammara Saleem,Ahmed Al-Harrasi,Saurabh Bhatia,Md. Sohanur Rahman,Fouad Damiri,Mohammed Berrada,Md. Habibur Rahman |
| Environmental Science and Pollution Research.2022;29(31)46385 |
| [DOI] |
|
| 21 | Nanoparticulate lipid dispersions for bromocriptine delivery: Characterization and in vivo study | |
| Elisabetta Esposito,Paolo Mariani,Laura Ravani,Catia Contado,Mattia Volta,Simone Bido,Markus Drechsler,Serena Mazzoni,Enea Menegatti,Michele Morari,Rita Cortesi |
| European Journal of Pharmaceutics and Biopharmaceutics.2012;80(2)306 |
| [DOI] |
|
| 22 | Bromocriptine therapy: Review of mechanism of action, safety and tolerability | |
| Faiza Naz,Abdul Malik,Muhammad Riaz,Qaisar Mahmood,Malik Hassan Mehmood,Ghulam Rasool,Zahed Mahmood,Mazhar Abbas |
| Clinical and Experimental Pharmacology and Physiology.2022;49(8)903 |
| [DOI] |
|
